Submissions

Author Guidelines

Authors are invited to make a submission to this journal. All submissions will be assessed by an editor to determine whether they meet the aims and scope of this journal. Those considered to be a good fit will be sent for peer review before determining whether they will be accepted or rejected.

Before making a submission, authors are responsible for obtaining permission to publish any material included with the submission, such as photos, documents and datasets. All authors identified on the submission must consent to be identified as an author. Where appropriate, research should be approved by an appropriate ethics committee in accordance with the legal requirements of the study's country.

An editor may desk reject a submission if it does not meet minimum standards of quality. Before submitting, please ensure that the study design and research argument are structured and articulated properly. The title should be concise and the abstract should be able to stand on its own. This will increase the likelihood of reviewers agreeing to review the paper. When you're satisfied that your submission meets this standard, please follow the checklist below to prepare your submission.

1. SUBMISSION OF MANUSCRIPTS

Authors should note that manuscript submission to the International Journal of Bioinformatics and AI in Healthcareimplies that the content has not been previously published or submitted elsewhere, except as a brief abstract or as part of conference proceedings.

Once the manuscript and accompanying materials are prepared following the Author Guidelines, manuscripts should be submitted through our online submission portal at https://globalmedsciencejournals.com/index.php/IJBAIH/about/submissions.

During the submission process, the submitting author will be prompted to provide an ORCID iD, a unique researcher identifier, to distinguish their work from that of other authors. Learn more about ORCID here.

For any assistance with the submission process, please contact us at: [email protected]. 

2. AIMS & SCOPE

The International Journal of Bioinformatics and AI in Healthcare aims to be the premier source of cutting-edge research in the integration of bioinformatics and artificial intelligence for healthcare advancements. This journal is the first choice for researchers and practitioners in bioinformatics, AI, and healthcare fields to publish novel findings, methodologies, and applications that drive innovation in medical science and patient care.

Each quarterly issue of the International Journal of Bioinformatics and AI in Healthcare features peer-reviewed articles on topics including but not limited to genomic and proteomic data analysis, clinical decision support systems, predictive modelling, medical imaging and signal processing, healthcare data management, drug discovery, and natural language processing in healthcare. Contributions may include original research articles, review papers, "Methods and Applications" articles, case studies, and systematic reviews that bridge the gap between computational science and healthcare practices.

Papers presented at relevant scientific symposia and conferences are also featured, alongside independent research that showcases pioneering work in bioinformatics, machine learning, and healthcare informatics.

The International Journal of Bioinformatics and AI in Healthcare is independently published, supporting a diverse, global readership that includes bioinformaticians, healthcare professionals, data scientists, and academics. The journal seeks to inspire interdisciplinary collaboration and facilitate the translation of bioinformatics and AI innovations into real-world healthcare improvements.

3. MANUSCRIPT CATEGORIES AND REQUIREMENTS

i. Original Research Articles

• Word limit: 3,500 words (max), excluding abstract and references
• Abstract: Structured with sub-headings: Background, Objectives, Methods, Results, Conclusion
• References: 60 references (max)
• Figures/Tables: Maximum of 8 figures and tables combined
• Description: Original research articles should report novel findings and methodologies in bioinformatics or AI as applied to healthcare.

Original Research Articles should be formatted as follows:

• Abstract
• Keywords
• Background
• Objectives
• Materials and Methods
• Results
• Discussion
• Conclusion
• References 

ii. Review Articles

• Word limit: 5,000 words (max), excluding references
• Abstract: Unstructured, summarizing the scope and key points
• References: 100 references (max)
• Figures/Tables: Up to 6 figures and tables
• Description: Review articles should provide a comprehensive overview of a specific topic within bioinformatics and AI in healthcare, including recent advancements, trends, and future directions.Case Studies

• Word limit: 2,000 words (max), excluding references
• Abstract: Brief overview of the case
• References: 25 references (max)
• Figures/Tables: Up to 4 figures and tables
• Description: Case studies should highlight unique applications of bioinformatics or AI in clinical settings, demonstrating the practical impact of these tools in healthcare.

iii. Methods and Applications

• Word limit: 3,000 words (max), excluding abstract and references
• Abstract: Structured with sub-headings: Objective, Methodology, Application, Conclusion
• References: 50 references (max)
• Figures/Tables: Maximum of 6 figures and tables
• Description: Methods and Applications articles should describe innovative techniques, software, or computational tools relevant to bioinformatics or AI in medicine, with applications demonstrated in a healthcare context. 

iv. Short Communications

• Word limit: 1,500 words (max), excluding references
• Abstract: Brief summary
• References: 20 references (max)
• Figures/Tables: Up to 3 figures and tables
• Description: Short Communications are concise reports on preliminary findings or significant advances that may require further investigation.

Each manuscript should follow the designated structure and adhere to these requirements to facilitate the review process and maintain consistency across published works in the International Journal of Bioinformatics and AI in Healthcare.

v. Invited Articles and Reviews

The International Journal of Bioinformatics and AI in Healthcare may, at times, invite original research articles and comprehensive reviews on emerging or significant topics that warrant in-depth coverage or unique presentation. These invited contributions are intended to provide expert insights and to stimulate discussion within the bioinformatics and healthcare AI communities.

Invited articles and reviews will undergo the same rigorous peer-review process as standard submissions. Upon acceptance, the Editor-in-Chief may decide to publish these works both in print and online, or online only, depending on the relevance and nature of the content.

vi. Book Reviews:

• Purpose: Book reviews should offer a balanced critique, providing both an objective overview and an assessment of the book’s value to practitioners, researchers, and students within the journal's scope.
• Word Limit: 800–1,200 words
• Structure:
1. Introduction: Briefly introduce the book, including the title, author(s), publisher, publication year, and total pages.
2. Content Summary: Provide an overview of the book’s main themes, chapters, and topics covered.
3. Critical Evaluation: Analyze the book’s strengths and weaknesses, relevance to the field, and contributions to bioinformatics, AI, or healthcare. Mention the intended audience and whether the book meets their needs effectively.
4. Conclusion: Summarize the overall impression of the book and provide a recommendation (e.g., highly recommended, recommended with reservations, or not recommended).

• Formatting:
• References: If other works are cited in the review, include a short reference list (up to 5 references).
• Quotations: Use brief quotations from the book as necessary to illustrate points, ensuring proper citation.
• Disclosure: If the reviewer has any relationship with the author(s) or publisher (e.g., prior collaborations, same institution), this should be disclosed at the end of the review.

• Submission Requirements:
• Include the full citation of the book at the beginning of the review.
• Reviews must be original and should not have been published elsewhere.
• Provide contact information for the reviewer.

• Review Process: Book reviews are reviewed by the editorial team to ensure they meet journal standards for clarity, fairness, and relevance.

vii. Conference/Workshop/CME and Events Articles:

• Purpose: Event articles should provide a clear, informative summary of the event’s main themes, notable presentations, innovations introduced, and overall impact on bioinformatics, AI, or healthcare. The review should highlight content relevant to researchers, clinicians, and other professionals in the field.
• Word Limit: 1,200–1,800 words
• Structure:

1. Introduction: Include the event’s name, organizer, dates, location (if applicable), and format (online, offline, hybrid).
2. Overview of Themes and Topics: Summarize the event's main themes, focus areas, and significant topics covered, including any specific tracks or sessions that are relevant to the journal’s audience.
3. Key Presentations and Highlights: Discuss notable presentations, workshops, or discussions. Mention prominent speakers, major research findings, new technologies, or case studies shared.
4. Innovations and Trends: Identify any emerging trends, innovations, or novel approaches introduced that could impact the future of bioinformatics, AI in healthcare, or clinical practice.
5. Critical Analysis and Takeaways: Provide an assessment of the event’s relevance and effectiveness, including any actionable takeaways, practical applications, or gaps identified.
6. Conclusion: Summarize the overall value of the event and its contributions to the field, and recommend whether future events organized by this group might be beneficial to readers.

• Formatting:
• References: Include references if citing specific studies, presentations, or previously published research (up to 10 references).
• Disclosure: If the author has any relationship with the event organizers, sponsors, or speakers (e.g., speaking engagement, organizational membership), this should be disclosed at the end of the article.
• Submission Requirements:
• Event articles should be original and not published elsewhere.
• Include contact information for the author.
• If available, provide links to event recordings, supplementary materials, or relevant publications mentioned during the event.
• Review Process: Articles in this section are reviewed by the editorial team for relevance, clarity, and completeness to ensure they provide meaningful insights for the journal’s audience.

This section allows readers to stay informed on important gatherings and professional development opportunities in bioinformatics and healthcare AI, extending the value of these events beyond their immediate participants.

4. PREPARING THE MANUSCRIPT FOR SUBMISSION

Parts of the Manuscript

The manuscript should be submitted as separate files: one main text file and individual files for each figure.

1. Title Page

• Manuscript Title: A concise, descriptive title that reflects the content and includes relevant keywords.
• Running Title: A short version of the title (max 40 characters) for header use.
• Authors: Full names of all authors with their highest degrees and institutional affiliations where the work was conducted.
• Funding and Conflict of Interests: Clearly indicate funding sources and any conflicts of interest, as outlined in the journal’s Funding and Conflicts of Interest policy.
• Corresponding Author: Name and contact details (address, telephone, and email). Note that this email will be published, and post-acceptance correspondence will be directed here.
• Meeting Information (if applicable): Include society name, location (city, state, country), and exact date if the manuscript was presented at a meeting.
• Acknowledgments: Mention any contributions from individuals who do not meet authorship criteria but contributed to the work. Acknowledgment of financial or material support is also encouraged.

2. Abstract, Keywords, and Level of Evidence

• Title: The title should be brief, informative, and contain major keywords relevant to the study, avoiding abbreviations.
• Authorship: Ensure all authors listed meet the authorship criteria outlined in the journal’s Authorship policy, as explained in the Editorial Policies and Ethical Considerations section.
• Acknowledgments: List contributors who do not qualify for authorship, with their permission. Acknowledge any financial or material support received. It is not appropriate to thank anonymous reviewers in this section.
• Conflict of Interest Statement: Authors must provide a conflict of interest statement during submission. All co-authors should agree with the final statement. Refer to the ‘Conflict of Interest’ section in Editorial Policies and Ethical Considerations for guidance.
• Abstract: An abstract is required for certain manuscript types. For specifics on which manuscript types require an abstract, refer to the ‘Manuscript Types and Criteria’ section. The abstract should provide a structured summary of the study, with key information on the objectives, methods, results, and conclusion.
• Keywords: Include 3–5 keywords to assist with indexing and search optimization.
• Level of Evidence: Required for original reports and systematic reviews, indicating the strength of evidence provided in the study. 

3. Main Text

The main text should be organized logically and clearly to convey the study's objectives, methods, findings, and conclusions. For detailed formatting guidance, please refer to the Manuscript Types and Criteria section. Manuscripts should follow the designated structure per article type (e.g., Introduction, Methods, Results, Discussion, Conclusion). 

4. Data Reporting

While a p-value of <0.05 is traditionally considered statistically significant, authors should focus on the clinical significance of findings by reporting effect sizes (e.g., mean differences, odds ratios, hazard ratios, or regression coefficients) to indicate the strength of associations between variables and outcomes. Additionally, confidence intervals should be reported to clarify the precision of effect sizes.

5. References

References should be numbered consecutively as they appear in the text, using Arabic superscript numerals. For the detailed reference style, follow the AMA Manual of Style. Examples are as follows:

1. Esteva A, Kuprel B, Novoa RA, Ko J, Swetter SM, Blau HM, et al. Dermatologist-level classification of skin cancer with deep neural networks. Nature. 2017;542(7639):115-8.
2. Alpaydin E. Introduction to Machine Learning. 4th ed. Cambridge (MA): MIT Press; 2020. 712 p.
3. National Institutes of Health. Artificial intelligence at NIH: Advancing science and health through AI [Internet]. Available from: https://www.nih.gov/about-nih/what-we-do/nih-turning-discovery-into-health/artificial-intelligence-nih. Accessed 2024 Nov 5.

Journal abbreviations should follow Index Medicus standards.

6. Tables

Tables should be concise, informative, and complementary to the main text, not duplicative. Provide editable files rather than image-based tables. Lengthy tables (over three pages) should be included as supplemental materials.

7. Figure Legends

Legends should be clear and descriptive, enabling the figure to be understood without reference to the text. Define all symbols, abbreviations, and units of measurement used in the figure.

8. Scattergram for Hearing Levels

For manuscripts discussing hearing levels, the International Journal of Bioinformatics and AI in Healthcare requires compliance with the American Academy of Otolaryngology – Head and Neck Surgery's minimal reporting standards for audiometric data. While authors may analyze data as they see fit, a standardized data set must be presented for comparison across studies.

9. Figures

Figures should be high quality for peer review. Various formats, sizes, and resolutions are acceptable initially, but post-acceptance figures require specific formatting. Each pane in a multi-paneled figure is counted as an individual figure. Figures in color can be reproduced online at no extra charge, but line figures (e.g., charts and graphs) should be provided in black and white for clarity if printed by readers in grayscale. Color printing in hard copies is available for an additional fee.

10. Video Requirements

Videos should independently convey the entire procedure or technique, with title pages including the procedure title, author, and affiliation. Videos should be edited for smooth flow and transitions, with all narration in English. Key landmarks, instruments, and settings should be labeled, with narration as appropriate. Videos must be submitted in MP4 format, compatible with most browsers. If patient footage is included, adhere to the Human Studies and Subjects guidelines. 

10. Additional Files

• Appendices: Appendices provide essential information referred to in the main text and count toward word, reference, and figure/table limits. They should be uploaded as separate files and will be edited and typeset before publication.
• Supporting Information: Supplementary materials not essential to the article, like additional tables, figures, videos, and datasets, are published online only and do not count towards any limits. These materials are unedited.

If data, scripts, or other materials are available in public repositories, please reference these locations in the manuscript.

General Style Points

The following guidelines provide general advice on manuscript formatting and style:

• Manuscripts should follow the formatting guidelines in the American Medical Association Manual of Style (10th edition).
• Use double spacing throughout the manuscript, including references, figure legends, and tables, with a minimum of 1-inch margins on all sides.
• Start each table on a new page.
• Begin the references on a separate page after the acknowledgments section.
• The journal follows US-English spelling conventions.
• Define all abbreviations upon their first appearance in the text, as well as in each table and figure.
• Use metric units for all measurements, with optional English unit equivalents in parentheses if desired.

These points are intended to maintain clarity, consistency, and readability across all submissions.

Manuscript Preparation Tips: We offer various resources to help authors prepare their manuscripts for submission. For optimal visibility, authors are encouraged to contact us: [email protected].

Editing Support, Translation Support, Formatting Support: IJBAIH Editing Services provides expert assistance in English language editing, translation, manuscript formatting, and figure preparation, improving the likelihood of manuscript acceptance. For more information, please contact us.

Citing Resources Using Research Resource Identifiers (RRIDs). 

Where applicable, authors should include RRIDs in the manuscript text and list of keywords. Resources like antibodies, software tools, databases, and model organisms should be cited with their RRID, similar to standard citations. Specific requirements are as follows:

• Antibodies: Provide the vendor, catalog number, and RRID (e.g., "Wnt3 was localized using a rabbit polyclonal antibody C64F2 against Wnt3 (Cell Signaling Technology, Cat# 2721S, RRID: AB_2215411)").
• Model Organisms: Cite with the RRID alone (e.g., "Experiments were conducted in elegans strain SP304 (RRID)").

• Cell Lines: Include the cell line name, catalog number, and RRID (e.g., "Experiments were conducted in PC12 CLS cells (CLS Cat# 500311/p701_PC-12, RRID)").

• Tools, Software, and Databases: Provide the resource name, website (if available), and RRID (e.g., "Image analysis was conducted with CellProfiler Image Analysis Software, V2.0 (http://www.cellprofiler.org, RRID)").

Obtaining RRIDs

To find or create RRIDs, authors can use the Resource Identification Portal and follow these steps:

1. Search for the resource using the portal’s search features.
2. Click on the "Cite This" button to generate the citation, then insert it into the manuscript text.
3. If a resource is not listed in the portal, authors are encouraged to register it with the relevant authority. Detailed instructions are available in the "Resource Citation Guidelines" section of the portal.

For any difficulties with Research Resource Identifiers (RRIDs), please contact [email protected] for assistance.

These guidelines ensure compliance with best practices in resource identification, enhancing research reliability and facilitating resource traceability.

5. EDITORIAL POLICIES AND ETHICAL CONSIDERATIONS

Publication Policies and Procedures

The Editors, Editorial Board members, and publisher’s staff of the International Journal of Bioinformatics and AI in Healthcare are committed to upholding the highest ethical standards in publication, working to ensure the integrity and reliability of the scientific literature.

All submitted manuscripts are screened for plagiarism using iThenticate. The journal adheres to the Guidelines on Good Publication Practice issued by the Committee on Publication Ethics (COPE).

Exclusive Publication

The International Journal of Bioinformatics and AI in Healthcare reserves the exclusive right to publish all accepted manuscripts. Examples of research misconduct include, but are not limited to:

• Submission of duplicate publications with similar data (i.e., claiming the manuscript is original when it has been submitted or accepted by another journal)
• Falsification of data, copyright infringement, or misrepresentation of conflicts of interest
• Submission of work not authored by the submitter, presented as original (i.e., plagiarism)
• Misattribution of authorship, including allowing one’s name to appear as an author without substantial input or without agreement on the manuscript submission
• Self-plagiarism (reusing previously published material without proper citation)
• Failure to disclose conflicts of interest.

These guidelines are in place to maintain the highest ethical standards and foster trust in the research published by the journal.

Editorial Review and Acceptance

The acceptance criteria for all manuscripts are based on the quality, originality, and significance of the research for the journal’s readership. Manuscripts are sent for review only if the Editor-in-Chief determines that they meet the journal’s standards for quality and relevance. All manuscripts selected for peer review undergo a single-blind review process.

Manuscripts may be rejected at any stage of the peer review process, including after the submission of a revised version. Any internal discussions between the Editor-in-Chief, associate editor, and external reviewers are confidential and privileged.

Data Storage and Documentation

The International Journal of Bioinformatics and AI in Healthcare encourages data sharing whenever possible, unless ethical, privacy, or confidentiality concerns prevent this. Authors are encouraged, though not required, to make data, scripts, and other artifacts available via a publicly accessible data repository.

If original data is part of the study, at least one author must confirm that they had full access to all data in the study and take responsibility for data integrity and accuracy in analysis.

Human Studies and Subjects

For manuscripts reporting medical research involving human participants, authors must include a statement in the Methods section identifying the ethics committee that approved the study and confirming compliance with recognized ethical standards. Examples of standards include the Declaration of Helsinki, the US Federal Policy for the Protection of Human Subjects, and the European Medicines Agency Guidelines for Good Clinical Practice.

Images and information from individual participants will only be published if authors have obtained the individual’s free, prior, and informed consent. While authors do not need to submit a copy of the consent form, they must confirm that consent has been obtained when signing the author license to publish. GMSJ provides a standard patient consent form for authors who may need it.

Animal Studies

For studies involving animals, authors must include a statement in the Methods section that the study protocol and procedures were ethically reviewed and approved, along with the name of the approving body. Authors are encouraged to follow established animal research reporting standards, such as the ARRIVE guidelines, which cover aspects such as study design, statistical analysis, experimental procedures, animal housing, and husbandry.

Specific guidelines for compliance include:

• US Authors: Compliance with the US National Research Council's Guide for the Care and Use of Laboratory Animals and the US Public Health Service's Policy on Humane Care and Use of Laboratory Animals.
• UK Authors: Adherence to UK legislation under the Animals (Scientific Procedures) Act 1986 Amendment Regulations (SI 2012/3039).
• European Authors (outside the UK): Compliance with Directive 2010/63/EU on the protection of animals used for scientific purposes.

These requirements ensure that all human and animal studies adhere to the highest ethical standards in research.

Clinical Trial Registration

The journal requires that all clinical trials be prospectively registered in a publicly accessible database. Manuscripts reporting clinical trial results should include the trial registration number and the name of the trial registry at the end of the abstract. If a trial was not registered or was registered retrospectively, authors should provide an explanation for this in the manuscript. 

Research Reporting Guidelines

To ensure clear and accurate reporting, authors are expected to follow established research reporting standards, which facilitate transparency, reproducibility, and reader comprehension. Key guidelines include:

• CONSORT guidelines for randomized trials
• PRISMA guidelines for systematic reviews and meta-analyses

Species Names

For species mentioned in the title, abstract, or text, the common name should be followed by the scientific name (genus, species, and authority) in parentheses upon first use. Scientific names may be omitted in article titles for well-known species. If no English common name exists, only the scientific name should be used.

Genetic Nomenclature

Sequence variants should be described using both DNA and protein designations when appropriate. Variant nomenclature must comply with the current HGVS guidelines. For more information, visit HGVS, which provides examples of acceptable nomenclature.

Sequence Data

Authors are encouraged to submit nucleotide sequence data to any of the three main collaborative databases: DDBJ, EMBL, or GenBank. Submission to one database suffices, as data is regularly shared between DDBJ, EMBL, and GenBank. When referring to accession numbers, the suggested wording is: "These sequence data have been submitted to the DDBJ/EMBL/GenBank databases under accession number U12345." Submission links for nucleotide sequence data are:

• DNA Data Bank of Japan (DDBJ): ddbj.nig.ac.jp
• EMBL Nucleotide Archive: ac.uk/ena
• GenBank: ncbi.nlm.nih.gov/genbank

Protein sequence data should be submitted to one of the following repositories:

• Protein Information Resource (PIR): georgetown.edu
• SWISS-PROT: ch/sprot/sprot-top

These guidelines help standardize data reporting and ensure accessibility and traceability of genetic and protein information in published research.

Conflict of Interest

The journal requires all authors to disclose any potential conflicts of interest that could be perceived as influencing the authors' objectivity. Conflicts of interest may include, but are not limited to, financial interests, patents, stock ownership, company board memberships, advisory board participation, consultancy, or receipt of speaker fees. These must be disclosed if they are directly related to the work described in the manuscript. If no conflicts of interest exist, authors must declare this at submission. The corresponding author is responsible for ensuring that all authors are aware of this policy and that all relevant relationships are disclosed upon submission.

Funding

Authors should list all funding sources in the Acknowledgments section, ensuring the accuracy of funder names. For assistance with correct funder nomenclature, refer to the Open Funder Registry. 

Authorship

Authors should meet the following ICMJE criteria for authorship:

1. Made substantial contributions to the study's conception, design, data acquisition, or data analysis and interpretation;
2. Contributed to drafting or critically revising the manuscript for intellectual content;
3. Provided final approval of the version to be published and taken public responsibility for appropriate portions of the content; and
4. Agreed to be accountable for the work's accuracy and integrity, ensuring that any concerns are investigated and resolved.

Individuals who do not meet authorship criteria may be acknowledged as collaborators in the Acknowledgments section.

Artificial Intelligence Generated Content (AIGC)

Artificial Intelligence tools—such as ChatGPT and similar large language models (LLMs)—cannot meet the requirements for authorship as they lack the ability to independently initiate research, design studies, or assume accountability for published work. In accordance with COPE's guidelines, these tools cannot be listed as authors. If an AI tool was used to assist with manuscript preparation, this should be transparently disclosed in the Methods or Acknowledgments section. The author retains full responsibility for verifying the accuracy of any content generated by such tools and for referencing any supporting work. Basic editing tools for spelling, grammar, and general editing fall outside this requirement. The journal’s editor reserves the right to assess the appropriateness of AI tool use in each manuscript.

ORCID

To support authors throughout the publishing process, the journal requires the submitting author to provide an ORCID iD upon submission. This identifier is simple to set up and helps distinguish authorship across publications. For more information, click here.

6. AUTHOR LICENSING

If a manuscript is accepted for publication, the corresponding author will receive an email with instructions to submit copyright or license agreement along with a format. The corresponding author will be required to complete a copyright or license agreement on behalf of all co-authors.

Authors have the option to publish their work under the journal’s standard copyright agreement or to choose Open Access under a Creative Commons License.

7. PUBLICATION PROCESS AFTER ACCEPTANCE

Accepted Article Received in Production

Once an article is accepted and received by IJBAIH's production team, the corresponding author will receive an email prompting them to log in or register with GMSJ Author Services. At this stage, the corresponding author will be asked to sign a publication license.

Proofs

After typesetting, the author will receive an email with instructions for downloading a PDF of the typeset page proof, along with any required forms and detailed instructions for reviewing and returning the proof.

The corresponding author is responsible for reviewing all content, including any editorial changes, to ensure accuracy. Authors are urged to check proofs thoroughly, as they are accountable for all statements made in the work. Proofs should be returned within 48 hours of receipt.

Publication Charges

• Free Online Color: Color figures are published online free of charge.
• Charges for Color in Print: Authors wishing to print color figures in the journal’s print edition will incur a fee. Upon publication at Early View, authors will receive a color charge agreement through email. Payment options include immediate payment by credit or debit card or requesting an invoice. If authors opt not to pay for color printing, the figures will appear in black and white in the print edition.

This process ensures that authors are actively involved in the final steps of publication, ensuring accuracy and clarity in both online and print formats.

Early View

The journal provides rapid online publication through GMSJ Early View service for a small fee. Early View articles (Online Version of Record) are published ahead of their inclusion in a regular or print issue. Please note that there may be a brief delay between receipt of corrections and online publication, as proofs must undergo final review by Editors.

Once an article is published on Early View, no additional changes can be made. Each Early View article is fully citable, with an assigned publication date and DOI, allowing authors to share their research promptly and ensuring that it can be accurately cited before print publication.

8. POST PUBLICATION

Access and Sharing

Once the article is published online:

• The author will receive an email alert if they have requested it.
• A link to the published article can be shared via social media.
• The author will have free access to the article by accepting the Terms & Conditions of use.
• The corresponding author and co-authors can nominate up to ten colleagues to receive a publication alert and free online access to the article.
• Print copies of the article can be ordered, with instructions provided at the proofing stage. 

9. EDITORIAL OFFICE CONTACT DETAILS

• Publisher’s Contact: Send corrected page proofs and other relevant materials to the Senior Production Editor at [email protected]
• Managing Editor: For questions about manuscript types, author guidelines, or other concerns, contact the Managing Editor at [email protected].
• Peer Review Coordinator: For queries about manuscript uploading and status, reach out to the Peer Review Coordinator at [email protected].

10. SOCIAL MEDIA PROMOTION

The journal is pleased to promote published articles via social media to broaden the reach of authors’ research. Authors can contribute to this effort by sharing their work on their own social media platforms and using hashtags or tags associated with the journal to further amplify visibility.